Summaries of studies that focus on cellular actions of metformin to activate AMPK, reduce generation of reactive oxygen species, improve vascular function, mediate anti-inflammatory effects and the potential to treat cancer and neurodegenerative diseases. This evidence concerns the gene PRKAA1 and cancer.